GENERAL ATLANTIC LLC 13D/13G Filings for CinCor Pharma, Inc. (CINC)

GENERAL ATLANTIC LLC 13D and 13G filings for CinCor Pharma, Inc.:

  • Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
  • Shares have been adjusted for stock splits.
Time period
Reported
DateTime		 Transaction
Date		 Type Company
Symbol		 Filed By
Symbol		 Shares Owned
% Owned		 Shares Vs. Prev Report View
2023-02-28
4:16 pm
Sale		 2023-02-24 13D CinCor Pharma, Inc.
CINC		 GENERAL ATLANTIC LLC 0
0.000%		 -4,209,470decrease
(Position Closed)		 Filing
2023-01-11
3:01 pm
Purchase		 2023-01-09 13D CinCor Pharma, Inc.
CINC		 GENERAL ATLANTIC LLC 4,209,470
9.600%		 83,000increase
(+2.01%)		 Filing
2022-01-21
1:07 pm
Purchase		 2022-01-11 13D CinCor Pharma, Inc.
CINC		 GENERAL ATLANTIC LLC 4,126,470
11.300%		 4,126,470increase
(New Position)		 Filing